Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

IMNM Immunome, Inc.
$22.16 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IMNM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.4B
Enterprise value 1.8B
Trailing PE -4.4290000915527
Forward PE -8.9244
PEG Ratio 0.26574000549316
Enterprise to EBITDA -8.622
Enterprise to revenue 182.217
Price to book MRQ 7.6997914
Price to sales TTM 252.61183

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 9.7M
EBITDA 990.0K
Diluted EPS TTM -2.96
Total Cash (MRQ) 272.6M
Current ratio (MRQ) 8.902
Operating Cash Flow (TTM) -185026000

IMNM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent IMNM News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.